MOD-GRF (1-29) + Ipamorelin Blend 10mg
CAS: 863288-34-0 / 170851-70-4
MOD-GRF (1-29) + Ipamorelin 10mg Blend by BioPeptides is a high-purity research-grade peptide formulation developed for advanced laboratory studies of growth hormone signaling, receptor selectivity, and endocrine pathway dynamics. Synthesized using precision solid-phase peptide synthesis and purified to ≥99% HPLC, this peptide blend provides excellent molecular stability and reproducibility. Identified by CAS 863288-34-0 (MOD-GRF 1-29) and CAS 170851-70-4 (Ipamorelin), it is widely used in controlled in-vitro research across Europe and the United States.
$210.00
Research Use Only
Research Overview
MOD-GRF (1-29) + Ipamorelin is a research peptide blend used to investigate growth hormone axis activation through complementary signaling pathways.
Researchers study this formulation to analyze receptor-specific signaling mechanisms and coordinated endocrine responses.
The blend enables controlled experimental evaluation of dual-pathway GH signaling dynamics.
It is commonly incorporated into laboratory studies exploring endocrine pathway modulation and peptide-receptor interactions.
Scientific Background
MOD-GRF (1-29) is a modified fragment of growth hormone-releasing hormone engineered to improve stability and resistance to enzymatic degradation.
Ipamorelin is a selective growth hormone secretagogue receptor (GHS-R) agonist widely studied for its receptor specificity.
Together, these peptides allow researchers to explore coordinated activation of GHRH and ghrelin receptor signaling pathways.
The combination supports investigations into endocrine pathway regulation and growth hormone signaling mechanisms.
Mechanistic Research Perspective
- GHRH receptor activation research
- Selective ghrelin receptor signaling analysis
- Dual-pathway growth hormone axis activation models
- Receptor cross-talk investigation
- Peptide-mediated endocrine signaling studies
Primary Research Applications
Growth Hormone Axis Research: The blend is used to study coordinated activation of growth hormone signaling pathways in laboratory research models.
Receptor Signaling Studies: Researchers investigate how GHRH receptor activation interacts with ghrelin receptor signaling in endocrine research.
Pulsatile Endocrine Signaling Models: The peptide combination supports experiments analyzing temporal hormone signaling patterns.
Cellular & Molecular Biology: Laboratories incorporate the blend into cell-based assays to examine downstream transcriptional and signaling responses.
Comparative Endocrine Pathway Research: The blend enables comparison of individual receptor activation versus coordinated signaling responses.
Molecular Characteristics
- Compound Name: MOD-GRF (1-29) + Ipamorelin Blend
- CAS Numbers: 863288-34-0 / 170851-70-4
- Peptide Class: GHRH analog + GHS-R agonist
- Form: Lyophilized peptide powder blend
- Purity: ≥99% HPLC verified
- Unit Size: 10 mg research peptide blend
Stability Profile and Storage Recommendations
- Store lyophilized peptides at −20°C
- Protect from moisture and light exposure
- Avoid repeated freeze–thaw cycles
- Reconstitute using sterile laboratory-grade solvent
- Seal vial tightly after use
Solubility and Preparation Considerations
- Soluble in sterile bacteriostatic water
- Compatible with buffered aqueous laboratory solutions
- Suitable for peptide research protocols
- Applicable in receptor signaling assay preparation
- Compatible with cell culture research models
Technical Specifications
product Name
MOD-GRF (1-29) + Ipamorelin Blend 10mg
brand
BioPeptides
cas
863288-34-0 / 170851-70-4
purity
≥99% (HPLC verified)
form
Lyophilized peptide powder blend
synthesis
Solid-phase peptide synthesis (SPPS)
analytical
HPLC and mass spectrometry verification
molecular Structure
Dual-peptide GH-axis signaling blend
stability
Stable under −20°C storage conditions
Analytical Validation and Quality Assurance
- High-resolution HPLC purity testing
- Peptide identity verification
- Structural integrity analysis
- Batch-to-batch consistency validation
- Peptide stability testing
Regulatory and Compliance Statement
MOD-GRF (1-29) + Ipamorelin supplied by BioPeptides is intended strictly for laboratory research use only. It is not approved for human consumption, veterinary use, therapeutic applications, or medical treatments.
Frequently Asked Questions
The blend is primarily used in laboratory studies investigating growth hormone axis signaling, receptor selectivity, and endocrine pathway interactions.
MOD-GRF activates the GHRH receptor while Ipamorelin stimulates the ghrelin receptor, allowing researchers to investigate coordinated GH signaling pathways.
CAS numbers uniquely identify each peptide, ensuring accurate documentation, traceability, and reproducibility in research laboratories.
Yes. The blend is widely used in controlled in-vitro research models involving receptor assays and endocrine pathway studies.
It is commonly used in endocrinology research, molecular biology, receptor pharmacology, and peptide signaling studies.
The blend enables simultaneous activation of complementary signaling pathways, improving research efficiency and experimental consistency.
The peptides should be stored at −20°C in lyophilized form and protected from moisture and light.
BioPeptides provides high-purity peptides with verified CAS documentation and reliable international supply for professional research laboratories.